Cardlytics, Inc.
US ˙ NasdaqGM ˙ US14161W1053

SecurityCDLX / Cardlytics, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership172,008 shares
Latest Disclosed Value $ 180,608
Invesco Ltd. reports 1.11% increase in ownership of CDLX / Cardlytics, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 172,008 shares of Cardlytics, Inc. (US:CDLX) valued at $180,608 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 170,122 shares of Cardlytics, Inc.. This represents a change in shares of 1.11% during the quarter. The current value of the position is $104,942 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CARDLYTICS COM 14161W105 172,008 1,886 1.11 181 -7.69 0.0000
2026-02-19 2025-12-31 13F CARDLYTICS COM 14161W105 170,122 46,973 38.14 196 -34.78 0.0000
2025-11-13 2025-09-30 13F CARDLYTICS COM 14161W105 123,149 22,671 22.56 299 81.21 0.0000
2025-08-13 2025-06-30 13F CARDLYTICS COM 14161W105 100,478 3,424 3.53 165 -6.25 0.0000
2025-05-12 2025-03-31 13F CARDLYTICS COM 14161W105 97,054 24,731 34.20 177 -34.33 0.0000
2025-02-13 2024-12-31 13F CARDLYTICS COM 14161W105 72,323 -50 -0.07 268 16.02 0.0000
2024-11-12 2024-09-30 13F CARDLYTICS COM 14161W105 72,373 490 0.68 232 -60.85 0.0000
2024-08-13 2024-06-30 13F CARDLYTICS COM 14161W105 71,883 -620,832 -89.62 590 -94.12 0.0001
2024-05-14 2024-03-31 13F CARDLYTICS COM 14161W105 692,715 552,209 393.01 10,037 675.66 0.0022
2024-02-13 2023-12-31 13F CARDLYTICS COM 14161W105 140,506 -662,735 -82.51 1,294 -90.24 0.0003
2023-11-13 2023-09-30 13F CARDLYTICS COM 14161W105 803,241 677,354 538.07 13,253 1,567.04 0.0036
2023-08-11 2023-06-30 13F CARDLYTICS COM 14161W105 125,887 -582 -0.46 796 85.31 0.0002
2023-05-12 2023-03-31 13F CARDLYTICS COM 14161W105 126,469 109,123 629.10 429 329.00 0.0001
2023-02-13 2022-12-31 13F CARDLYTICS COM 14161W105 17,346 85 0.49 100 -38.27 0.0000
2022-11-14 2022-09-30 13F CARDLYTICS COM 14161W105 17,261 -265 -1.51 162 -58.57 0.0001
2022-08-15 2022-06-30 13F CARDLYTICS COM 14161W105 17,526 -649 -3.57 391 -60.90 0.0001
2022-05-16 2022-03-31 13F CARDLYTICS COM 14161W105 18,175 2,512 16.04 1,000 -3.38 0.0003
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 15,663 -187 -1.18 1,035 -22.24 0.0002
2021-11-15 2021-09-30 13F CARDLYTICS COM 14161W105 15,850 2,651 20.08 1,331 -20.54 0.0003
2021-08-17 2021-06-30 13F CARDLYTICS COM 14161W105 13,199 -53,819 -80.31 1,675 -77.22 0.0004
2021-05-17 2021-03-31 13F CARDLYTICS COM 14161W105 67,018 -2,935 -4.20 7,352 -26.38 0.0020
2021-02-16 2020-12-31 13F CARDLYTICS COM 14161W105 69,953 69,953 9,987 0.0029
2020-11-16 2020-09-30 13F CARDLYTICS COM 14161W105 0 -14,247 -100.00 0 -100.00
2020-08-14 2020-06-30 13F CARDLYTICS COM 14161W105 14,247 -2,304 -13.92 997 72.19 0.0004
2020-05-15 2020-03-31 13F CARDLYTICS COM 14161W105 16,551 -115,268 -87.44 579 -93.01 0.0002
2020-02-14 2019-12-31 13F CARDLYTICS COM 14161W105 131,819 -31,236 -19.16 8,286 51.59 0.0026
2019-11-14 2019-09-30 13F CARDLYTICS COM 14161W105 163,055 122,277 299.86 5,466 416.15 0.0014
2019-08-14 2019-06-30 13F/A-1 CARDLYTICS COM 14161W105 40,778 40,778 1,059 0.0003
2019-08-14 2019-06-30 13F CARDLYTICS COM 14161W105 40,778 1,059 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.